Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease

Roberta Pisi, Marina Aiello, Andrea Zanini, Panagiota Tzani, Davide Paleari, Emilio Marangio, Antonio Spanevello, Gabriele Nicolini, Alfredo Chetta

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Background: We investigated whether a relationship between small airways dysfunction and bronchodilator responsiveness exists in patients with chronic obstructive pulmonary disease (COPD). Methods: We studied 100 (20 female; mean age: 68±10 years) patients with COPD (forced expiratory volume in 1 second [FEV1]: 55% pred ±21%; FEV1/forced vital capacity [FVC]: 53%±10%) by impulse oscillometry system. Resistance at 5 Hz and 20 Hz (R5 and R20, in kPa·s·L-1) and the fall in resistance from 5 Hz to 20 Hz (R5 – R20) were used as indices of total, proximal, and peripheral airway resistance; reactance at 5 Hz (X5, in kPa·s·L-1) was also measured. Significant response to bronchodilator (salbutamol 400 µg) was expressed as absolute (≥0.2 L) and percentage (≥12%) change relative to the prebronchodilator value of FEV1 (flow responders, FRs) and FVC (volume responders, VRs). Results: Eighty out of 100 participants had R5 – R20 >0.03 kPa·s·L-1 (> upper normal limit) and, compared to patients with R5 – R20 ≤0.030 kPa·s·L-1, showed a poorer health status, lower values of FEV1, FVC, FEV1/FVC, and X5, along with higher values of residual volume/total lung capacity and R5 (P1.

Original languageEnglish
Pages (from-to)1191-1197
Number of pages7
JournalInternational Journal of COPD
Volume10
DOIs
Publication statusPublished - Jun 19 2015

Fingerprint

Bronchodilator Agents
Forced Expiratory Volume
Chronic Obstructive Pulmonary Disease
Vital Capacity
Oscillometry
Total Lung Capacity
Airway Resistance
Residual Volume
Albuterol
Vascular Resistance
Health Status

Keywords

  • Bronchodilator responsiveness
  • COPD
  • Small airways

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Public Health, Environmental and Occupational Health
  • Health Policy

Cite this

Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease. / Pisi, Roberta; Aiello, Marina; Zanini, Andrea; Tzani, Panagiota; Paleari, Davide; Marangio, Emilio; Spanevello, Antonio; Nicolini, Gabriele; Chetta, Alfredo.

In: International Journal of COPD, Vol. 10, 19.06.2015, p. 1191-1197.

Research output: Contribution to journalArticle

Pisi, Roberta ; Aiello, Marina ; Zanini, Andrea ; Tzani, Panagiota ; Paleari, Davide ; Marangio, Emilio ; Spanevello, Antonio ; Nicolini, Gabriele ; Chetta, Alfredo. / Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease. In: International Journal of COPD. 2015 ; Vol. 10. pp. 1191-1197.
@article{cb6b7fc17b58491cabdc6e032aa85f35,
title = "Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease",
abstract = "Background: We investigated whether a relationship between small airways dysfunction and bronchodilator responsiveness exists in patients with chronic obstructive pulmonary disease (COPD). Methods: We studied 100 (20 female; mean age: 68±10 years) patients with COPD (forced expiratory volume in 1 second [FEV1]: 55{\%} pred ±21{\%}; FEV1/forced vital capacity [FVC]: 53{\%}±10{\%}) by impulse oscillometry system. Resistance at 5 Hz and 20 Hz (R5 and R20, in kPa·s·L-1) and the fall in resistance from 5 Hz to 20 Hz (R5 – R20) were used as indices of total, proximal, and peripheral airway resistance; reactance at 5 Hz (X5, in kPa·s·L-1) was also measured. Significant response to bronchodilator (salbutamol 400 µg) was expressed as absolute (≥0.2 L) and percentage (≥12{\%}) change relative to the prebronchodilator value of FEV1 (flow responders, FRs) and FVC (volume responders, VRs). Results: Eighty out of 100 participants had R5 – R20 >0.03 kPa·s·L-1 (> upper normal limit) and, compared to patients with R5 – R20 ≤0.030 kPa·s·L-1, showed a poorer health status, lower values of FEV1, FVC, FEV1/FVC, and X5, along with higher values of residual volume/total lung capacity and R5 (P1.",
keywords = "Bronchodilator responsiveness, COPD, Small airways",
author = "Roberta Pisi and Marina Aiello and Andrea Zanini and Panagiota Tzani and Davide Paleari and Emilio Marangio and Antonio Spanevello and Gabriele Nicolini and Alfredo Chetta",
year = "2015",
month = "6",
day = "19",
doi = "10.2147/COPD.S82509",
language = "English",
volume = "10",
pages = "1191--1197",
journal = "International Journal of COPD",
issn = "1176-9106",
publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease

AU - Pisi, Roberta

AU - Aiello, Marina

AU - Zanini, Andrea

AU - Tzani, Panagiota

AU - Paleari, Davide

AU - Marangio, Emilio

AU - Spanevello, Antonio

AU - Nicolini, Gabriele

AU - Chetta, Alfredo

PY - 2015/6/19

Y1 - 2015/6/19

N2 - Background: We investigated whether a relationship between small airways dysfunction and bronchodilator responsiveness exists in patients with chronic obstructive pulmonary disease (COPD). Methods: We studied 100 (20 female; mean age: 68±10 years) patients with COPD (forced expiratory volume in 1 second [FEV1]: 55% pred ±21%; FEV1/forced vital capacity [FVC]: 53%±10%) by impulse oscillometry system. Resistance at 5 Hz and 20 Hz (R5 and R20, in kPa·s·L-1) and the fall in resistance from 5 Hz to 20 Hz (R5 – R20) were used as indices of total, proximal, and peripheral airway resistance; reactance at 5 Hz (X5, in kPa·s·L-1) was also measured. Significant response to bronchodilator (salbutamol 400 µg) was expressed as absolute (≥0.2 L) and percentage (≥12%) change relative to the prebronchodilator value of FEV1 (flow responders, FRs) and FVC (volume responders, VRs). Results: Eighty out of 100 participants had R5 – R20 >0.03 kPa·s·L-1 (> upper normal limit) and, compared to patients with R5 – R20 ≤0.030 kPa·s·L-1, showed a poorer health status, lower values of FEV1, FVC, FEV1/FVC, and X5, along with higher values of residual volume/total lung capacity and R5 (P1.

AB - Background: We investigated whether a relationship between small airways dysfunction and bronchodilator responsiveness exists in patients with chronic obstructive pulmonary disease (COPD). Methods: We studied 100 (20 female; mean age: 68±10 years) patients with COPD (forced expiratory volume in 1 second [FEV1]: 55% pred ±21%; FEV1/forced vital capacity [FVC]: 53%±10%) by impulse oscillometry system. Resistance at 5 Hz and 20 Hz (R5 and R20, in kPa·s·L-1) and the fall in resistance from 5 Hz to 20 Hz (R5 – R20) were used as indices of total, proximal, and peripheral airway resistance; reactance at 5 Hz (X5, in kPa·s·L-1) was also measured. Significant response to bronchodilator (salbutamol 400 µg) was expressed as absolute (≥0.2 L) and percentage (≥12%) change relative to the prebronchodilator value of FEV1 (flow responders, FRs) and FVC (volume responders, VRs). Results: Eighty out of 100 participants had R5 – R20 >0.03 kPa·s·L-1 (> upper normal limit) and, compared to patients with R5 – R20 ≤0.030 kPa·s·L-1, showed a poorer health status, lower values of FEV1, FVC, FEV1/FVC, and X5, along with higher values of residual volume/total lung capacity and R5 (P1.

KW - Bronchodilator responsiveness

KW - COPD

KW - Small airways

UR - http://www.scopus.com/inward/record.url?scp=84933521675&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84933521675&partnerID=8YFLogxK

U2 - 10.2147/COPD.S82509

DO - 10.2147/COPD.S82509

M3 - Article

AN - SCOPUS:84933521675

VL - 10

SP - 1191

EP - 1197

JO - International Journal of COPD

JF - International Journal of COPD

SN - 1176-9106

ER -